The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause
Clinical trial NCT04537351 · COMPLETED
Trial details
- NCT number
- NCT04537351
- Sponsor
- Cynata Therapeutics Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-24
- Primary completion
- 2022-04-27
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.